Nana Muazin

Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma

• Clinical Oncology Education

Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma

Nana Muazin June 15, 2026

CHICAGO — A landmark clinical trial set to be presented at the 2026 American Society of Clinical...

Read More Read more about Breakthrough in Liver Cancer Treatment: EMERALD-3 Trial Signals New Era for Unresectable Hepatocellular Carcinoma

The Shifting Landscape of Metastatic Breast Cancer: Rising Incidence Rates and the Paradox of Improving Survival

• Patient Advocacy and Support

The Shifting Landscape of Metastatic Breast Cancer: Rising Incidence Rates and the Paradox of Improving Survival

Nana Muazin June 14, 2026

Introduction In the complex and ever-evolving field of oncology, the narrative surrounding breast cancer has long been...

Read More Read more about The Shifting Landscape of Metastatic Breast Cancer: Rising Incidence Rates and the Paradox of Improving Survival

Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

• Genomics and Precision Medicine

Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

Nana Muazin June 14, 2026

In the rapidly accelerating era of precision medicine, the integration of genomics into routine clinical practice has...

Read More Read more about Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

A New Era in Genomic Medicine: Casgevy Cleared for NHS Use

• Genomics and Precision Medicine

A New Era in Genomic Medicine: Casgevy Cleared for NHS Use

Nana Muazin June 14, 2026

The landscape of modern medicine has undergone a seismic shift. For decades, patients suffering from severe inherited...

Read More Read more about A New Era in Genomic Medicine: Casgevy Cleared for NHS Use

The Silent Resilience: Susan Peluso’s Journey Through Stage 4 Ovarian Cancer and the Global Call for Early Detection

• Patient Advocacy and Support

The Silent Resilience: Susan Peluso’s Journey Through Stage 4 Ovarian Cancer and the Global Call for Early Detection

Nana Muazin June 14, 2026

Introduction: The "Before and After" of a Silent Killer In the landscape of modern oncology, few diagnoses...

Read More Read more about The Silent Resilience: Susan Peluso’s Journey Through Stage 4 Ovarian Cancer and the Global Call for Early Detection

Beyond the “All Clear”: Breast Cancer Canada Demands National Strategy for Survivorship Care

• Patient Advocacy and Support

Beyond the “All Clear”: Breast Cancer Canada Demands National Strategy for Survivorship Care

Nana Muazin June 13, 2026

TORONTO, ON – In the landscape of modern oncology, the words “you are cancer-free” or the “all...

Read More Read more about Beyond the “All Clear”: Breast Cancer Canada Demands National Strategy for Survivorship Care

Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

• Chemotherapy and Targeted Therapy

Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

Nana Muazin June 6, 2026

By [Your Name/Journalistic Staff] June 5, 2026 In a landmark decision that promises to reshape the landscape...

Read More Read more about Supreme Court Ruling Protects “Skinny Labeling,” Dealing Blow to Brand-Name Pharmaceutical Patent Strategies

The Genomic Frontier: How the Broad Institute is Redefining Modern Medicine

• Genomics and Precision Medicine

The Genomic Frontier: How the Broad Institute is Redefining Modern Medicine

Nana Muazin June 5, 2026 0

In the quiet corridors of laboratories in Cambridge, Massachusetts, a scientific revolution is unfolding. The Broad Institute...

Read More Read more about The Genomic Frontier: How the Broad Institute is Redefining Modern Medicine

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

• Chemotherapy and Targeted Therapy

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

Nana Muazin June 4, 2026 0

By Financial News Desk Shares of Switzerland-based biotechnology firm ADC Therapeutics plummeted by more than 50% on...

Read More Read more about Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

Embracing Our Mortality: The Crucial Conversation We Are Afraid to Have

• Survivorship and Post-Treatment

Embracing Our Mortality: The Crucial Conversation We Are Afraid to Have

Nana Muazin June 4, 2026 0

By Editorial Staff May 26, 2026 In the ancient book of Deuteronomy, the mandate is clear: "Choose...

Read More Read more about Embracing Our Mortality: The Crucial Conversation We Are Afraid to Have